Pharmaceuticals News

ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target Cancer Research UK to fully fund, sponsor, design, and execute CTA-enabling...

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Click Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (marketing authorization) for...

Company Announcement COPENHAGEN, Denmark and NORTH CHICAGO, Ill.; October 5, 2026 EPCORE DLBCL-2 is the first Phase 3 study of a bispecific antibody combination therapy to demonstrate statistically...

Company announcement No. 53 / 2026 Zealand Pharma - Completion of share buy-back program and related transactions (week 40 and 41, 2026) Copenhagen, Denmark, October 5, 2026 – Zealand Pharma A/S...

VALNEVA Declaration of shares and voting rights Status as of September 30, 2026__________________________________________________________________________________________ Company name:...

VALNEVA Déclaration d’actions et de droits de vote Statut au 30 septembre 2026__________________________________________________________________________________________ Dénomination sociale :...

AHA Hypertension: New analyses show substantial antihypertensive efficacy of aprocitentan in patients with obesity and those across the CKM continuum.

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunologic,...

Medicovestor announces FDA IND clearance for MC001, a novel pancreatic cancer ADC, and prepares for an international Phase 1 study.

– ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction – SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a...